Menovazin external solution. 40ml vial


Menovazin external solution. 40ml vial



Active substance:
100 ml of the preparation contains: levomenthol – 2.5 g; procaine hydrochloride (hydrochloride novocaine) – 1.0 g; benzocaine (benzocaine) – 1.0 g ;.
Ethanol (ethyl alcohol) 70% – to 100 ml.
Colorless transparent liquid with an odor of menthol.
Product form:
A solution for topical use the alcohol.
At 40, 50 ml vials of amber glass, sealed with plastic stoppers and screw caps.
50 ml vial-dispenser with drip and spray.
Each vial together with instructions for use placed in a pile of cardboard.
It allowed the full text of the instructions for use printed on the package.
Hypersensitivity to any one of the formulation components, disruption of the skin or inflammatory diseases of the skin at the site of the intended application (t. H. Dermatitis, eczema). Pregnancy, lactation, children under 18 years.
As the local anesthetic agent for neuralgia, myalgia, arthralgia and pruritic dermatoses.
pharmachologic effect
Pharmacological group:
Local anesthetic.
Pharmacological properties:
Combined preparation for external application. It has a local anesthetic action.
Levomenthol when applied to the skin it causes irritation of the nerve endings, dilates blood vessels of the skin surface, causing a feeling of coolness, accompanied by analgesic effect and relieve itching. It enhances the effect of anesthetic procaine and benzocaine.
Procaine – mestnoanesteziruyuschee means with moderate anesthetic activity. Blocking sodium channels, preventing the generation of pulses in the sensory nerve endings, and the conduction of impulses along nerve fibers.
Benzocaine – local anesthetic for surface anesthesia. It prevents the emergence of pain impulses in the sensory nerve endings and the conduct of the nerve fibers.
Conditions of supply of pharmacies
Without recipe.
side effects
Allergic reactions, contact dermatitis. Prolonged use of dizziness, weakness, decrease in blood pressure. In these cases, stop using the product.
Storage conditions
In the dark place at a temperature not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Topically applied to the skin over the affected area and triturated with or applied to the affected areas of the skin (pruritic dermatoses) 2-3 times a day.
The course of treatment depending on the therapeutic effect, but no more than 3-4 weeks. repeat the course if necessary.
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg


There are no reviews yet.

Add your review